Fine Comparison of the Efficacy and Safety Between GB242 and Infliximab in Patients with Rheumatoid Arthritis: A Phase III Study
2021 · Rheumatology and Therapy · 14 citations
https://doi.org/10.1007/s40744-021-00396-8
X
Xiaowei Gong
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
28
Papers
229
Citations
10
h-index
10
i10-index
Xiaowei Gong is an academic researcher from Hebei Medical University. The author has contributed to research in topics: Venous Thromboembolism Diagnosis and Management & COVID-19 Clinical Research Studies & SARS-CoV-2 and COVID-19 Research. The author has an h-index of 10, co-authored 24 publications.
Papers by this author
worksAssociated risk factors with disease severity and antiviral drug therapy in patients with COVID-19
2021 · BMC Infectious Diseases · 13 citations
https://doi.org/10.1186/s12879-021-06282-6
Clinical characteristics and mortality predictors among very old patients with pulmonary thromboembolism: a multicenter study report
2024 · BMC Pulmonary Medicine · 5 citations
https://doi.org/10.1186/s12890-023-02824-7
Notoginsenoside R1 Improved Hypoxic Pulmonary Hypertension by Inhibiting Glycolysis‐Mediated Pulmonary Arterial Vascular Remodeling
2025 · Canadian Respiratory Journal · 1 citations
https://doi.org/10.1155/carj/2884885
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat